Use of Compounds Sample Clauses

Use of Compounds. ‌ Where employees are directed by their supervisors to use particular compounds, the employees are not held responsible for any adverse effects resulting from the proper application of the compound.

Use of Compounds. As provided for in the then current Research Plan, each Party shall make available to the other Party free of charge appropriate numbers and amounts of BOEHRINGER Compounds or EVOTEC Compounds, as applicable, either in microtiter plates for screening or as a powder or solution in microtubes for secondary testing in specified biological assays within the Field. Each Party shall only use the Compounds of the other Party for the purposes of the Research Plan and as otherwise explicitly permitted under this Agreement and for no other purpose, except with the prior written consent of the other Party.

Use of Compounds. Research Compounds and Derived Compounds will be incorporated by Merck into Merck's chemical compound collection. It is understood that Merck may utilize Research Compounds and Derived Compounds for any purpose, including the provision of samples of such Compounds to third parties, subject to the license granted to Isis in the Isis Field. It is further understood that, subject to the limitations of paragraph 3.5 hereof, Merck may develop such Research Compounds and Derived Compounds for any purpose subject to any royalty obligations set forth in Article 5. Isis Compounds may be screened by Merck only for activity relative to Hepatitis C polymerase and other anti-viral activity and will be returned to Isis at the end of the Research Program, unless Merck is developing such Isis Compound(s) for any anti-viral indication. It is understood that should Merck thereafter abandon development of such Isis Compound(s), Merck will return such Isis Compound(s) to Isis at that time.

Use of Compounds. CombinatoRx agrees: 1. that the Compounds will be used only in CombinatoRx laboratories and only laboratory personnel under CombinatoRx's immediate and direct control or in laboratories directly contracted by CombinatoRx, whose personnel are bound by the terms of this Agreement; 2. to use the Compounds only for screening for the Purpose and NOT for any other purpose including the Commercial Purposes; 3. that the Compounds will be received, handled, stored, used and disposed of in compliance with all applicable laws, regulations and guidelines, and in accordance with safe and prudent practices, and will not be administered to human subjects or provided to any third parties, nor will any animals or plants exposed to the Compounds, or products of such animals or plants be used for food; and 4. that CombinatoRx has adequate systems, procedures and personnel to review and oversee arrangements for the receipt, handling, storage, use and disposal of experimental materials of the nature of the Compounds, and that it will ensure that all persons involved in receiving, handling, storing, using or disposing of the Compounds are adequately qualified by training and experience to do so safely and legally.

Use of Compounds. Roche shall not have any right to use any of the Compounds for any use except the development and commercialization of Products in the Field pursuant to the licenses granted to it in Section 5.2.1. Maxygen shall not have any right to use any of the Compounds for any use except (a) for the development of Products in the Field pursuant to this Agreement, and/or (b) as permitted by Sections 5.7 and 5.8 and Articles 6 and 18.